Dmitriy I. Shustov
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Dmitriy I. Shustov has a total of 66 co-authors. Here are the top co-authors by number of shared publications:
- Ilya Andreevich Fedotov
Рязанский государственный медицинский университет имени академика И.П. Павлова
17 shared publications - Ol'GA D. Tuchina
Moscow Research and Practical Centre for Narcology of the Department of Public Health
12 shared publications - Tat'Yana Vasil'Evna Agibalova
Moscow Research and Practical Centre for Narcology of the Department of Public Health
7 shared publications - Egor V. Leonov
Ryazan State Medical University
5 shared publications - Aleksey Vladimirovich Merinov
Ryazan State Med Univ, Ryazan, Russia
4 shared publications - Boris Yurievich Volodin
Ryazan State Medical University
4 shared publications
Latest Publications
- 30 September 2026
- Published by ECO-Vector LLC (Publications) in I.P. Pavlov Russian Medical Biological Herald
- Vol. 34 (3) , 335-346
Initial results of search for neuropsychological markers of the schizophrenia endophenotype in patients with synthetic cathinone-induced psychotic disorders: a cross-sectional study
BACKGROUND: The rising incidence of psychotic disorders (PDs) induced by synthetic cathinones (SCs) underscores the relevance of search for markers for differentiating this pathology from schizophrenia spectrum psychoses. AIM: To investigate neuropsychological markers of the schizophrenia endophenotype in patients with SC-induced psychotic disorders (SCIPD) and evaluate a possibility of their use in differential diagnosis. METHODS: This observational, cross-sectional, randomized study was conducted from September 2023 to December 2025. Participants were allocated into four groups: Group 1 (healthy controls, n=32); Group 2 (patients with psychostimulant dependence syndrome (PSDS), n=31)), Group 3 (patients with SCIPD, n=30), Group 4 (patients with schizophrenia, n=30). Neuropsychological markers of the schizophrenia endophenotype, selected based on data of meta-analyses, were evaluated using the following instruments: the Continuous Performance Test–Identical Pairs (CPT-IP; DPrime, and False Alarm Catch Rate parameters), the Trail Making Test (parameter Trail B Time and Trail B–Trail A Time difference score), the Stroop test (processing speed and accuracy/inhibition indices), and the Edinburgh Handedness Inventory–Laterality Quotient (EHI-LQ; dominant lateralization index). All tests were performed in the Inquisit computerized environment (Millisecond Inc., USA). RESULTS: The control group performed significantly better than all clinical groups on the DPrime (CPT-IP) and Trail B Time parameters. Group 3 did not differ from Group 4 in the main neurocognitive parameters, with the exception of a higher False Alarm Catch Rate (CPT-IP) and a more pronounced tendency to left-handedness (EHI-LQ). Between-group comparison across the full marker profile revealed significant differences between controls and all clinical groups, as well as between Groups 2 and 4 (p 0.05). Patients in Group 3 occupied an intermediate position between Groups 2 and 4, not differing significantly from them. CONCLUSION: TThe selected neuropsychological markers of schizophrenia endophenotype, primarily reflecting functioning of the dorsolateral prefrontal cortex, do not differentiate SCIPD from schizophrenia. The deficits of sustained attention and cognitive flexibility identified in patients with SCIPD, indistinguishable from those in schizophrenia, suggest hypofrontality and may point to premorbid vulnerability or dopamine sensitization as a mechanism of transformation into schizophrenia. The increased prevalence of left-handedness in the SCIPD group supports the hypothesis of the presence of a pre-existing schizophrenia endophenotype prior to the onset of substance use.
- 30 September 2026
- Published by ECO-Vector LLC (Publications) in I.P. Pavlov Russian Medical Biological Herald
- Vol. 34 (3) , 335-346
Initial results of search for neuropsychological markers of the schizophrenia endophenotype in patients with synthetic cathinone-induced psychotic disorders: a cross-sectional study
BACKGROUND: The rising incidence of psychotic disorders (PDs) induced by synthetic cathinones (SCs) underscores the relevance of search for markers for differentiating this pathology from schizophrenia spectrum psychoses. AIM: To investigate neuropsychological markers of the schizophrenia endophenotype in patients with SC-induced psychotic disorders (SCIPD) and evaluate a possibility of their use in differential diagnosis. METHODS: This observational, cross-sectional, randomized study was conducted from September 2023 to December 2025. Participants were allocated into four groups: Group 1 (healthy controls, n=32); Group 2 (patients with psychostimulant dependence syndrome (PSDS), n=31)), Group 3 (patients with SCIPD, n=30), Group 4 (patients with schizophrenia, n=30). Neuropsychological markers of the schizophrenia endophenotype, selected based on data of meta-analyses, were evaluated using the following instruments: the Continuous Performance Test–Identical Pairs (CPT-IP; DPrime, and False Alarm Catch Rate parameters), the Trail Making Test (parameter Trail B Time and Trail B–Trail A Time difference score), the Stroop test (processing speed and accuracy/inhibition indices), and the Edinburgh Handedness Inventory–Laterality Quotient (EHI-LQ; dominant lateralization index). All tests were performed in the Inquisit computerized environment (Millisecond Inc., USA). RESULTS: The control group performed significantly better than all clinical groups on the DPrime (CPT-IP) and Trail B Time parameters. Group 3 did not differ from Group 4 in the main neurocognitive parameters, with the exception of a higher False Alarm Catch Rate (CPT-IP) and a more pronounced tendency to left-handedness (EHI-LQ). Between-group comparison across the full marker profile revealed significant differences between controls and all clinical groups, as well as between Groups 2 and 4 (p 0.05). Patients in Group 3 occupied an intermediate position between Groups 2 and 4, not differing significantly from them. CONCLUSION: TThe selected neuropsychological markers of schizophrenia endophenotype, primarily reflecting functioning of the dorsolateral prefrontal cortex, do not differentiate SCIPD from schizophrenia. The deficits of sustained attention and cognitive flexibility identified in patients with SCIPD, indistinguishable from those in schizophrenia, suggest hypofrontality and may point to premorbid vulnerability or dopamine sensitization as a mechanism of transformation into schizophrenia. The increased prevalence of left-handedness in the SCIPD group supports the hypothesis of the presence of a pre-existing schizophrenia endophenotype prior to the onset of substance use.
- Open Access
- 31 August 2026
- Published by ECO-Vector LLC (Publications) in Consortium Psychiatricum
- Vol. 7 (3) , 4-14
Substance-induced psychotic disorders: hospitalization trends in the Russian Federation, 2000–2024
BACKGROUND: The prevalence of substance-induced psychotic disorders (SIPDs), particularly those induced by synthetic psychostimulants and high-potency cannabinoids, represents a global public health concern. АIM: To analyze the trends and factors associated with hospitalizations for SIPDs in the Russian Federation between 2000 and 2024. METHODS: A retrospective epidemiological study was conducted using annual aggregate population-level data from federal statistical surveillance. Variables included hospitalization rates for psychotic disorders induced by illegal and legal psychoactive substances, dependence syndromes, and the quantities of illicit drugs seized. Data were analyzed using nonparametric statistical methods. RESULTS: Two clusters were identified in the trends of the general drug use situation: 2000–2013 and 2014–2024. In the second period, the rate of hospitalizations for patients with SIPD was six times higher, and the structure of substance use-related morbidity underwent a transformation: a 2.9-fold decrease in the annual hospitalization rates for opioid dependence syndrome, accompanied by a 16.4-fold increase in hospitalizations for psychostimulant dependence syndrome, a 3.1-fold increase for cannabinoid dependence, and a 7.4-fold increase for dependence on other psychoactive substances and their combinations. According to the regression analysis, half of the variability in the hospitalization indicator for SIPD is explained by the hospitalization indicator for dependence on psychostimulants or other psychoactive substances and their combinations, while the other half is explained by the hospitalization rate for dependence on cannabinoids. CONCLUSION: The sixfold increase in the hospitalization rate for SIPDs observed in Russia since 2013 may be linked to changes in general drug use patterns — rise in the hospitalization rates for dependence syndromes on synthetic stimulants, cannabinoids and other psychoactive substances and their combinations, accompanied by a decline in hospitalizations for opioid dependence.
- 31 August 2026
- Published by ECO-Vector LLC (Publications) in Consortium Psychiatricum
- Vol. 7 (3) , 4-14
Open AccessSubstance-induced psychotic disorders: hospitalization trends in the Russian Federation, 2000–2024
BACKGROUND: The prevalence of substance-induced psychotic disorders (SIPDs), particularly those induced by synthetic psychostimulants and high-potency cannabinoids, represents a global public health concern. АIM: To analyze the trends and factors associated with hospitalizations for SIPDs in the Russian Federation between 2000 and 2024. METHODS: A retrospective epidemiological study was conducted using annual aggregate population-level data from federal statistical surveillance. Variables included hospitalization rates for psychotic disorders induced by illegal and legal psychoactive substances, dependence syndromes, and the quantities of illicit drugs seized. Data were analyzed using nonparametric statistical methods. RESULTS: Two clusters were identified in the trends of the general drug use situation: 2000–2013 and 2014–2024. In the second period, the rate of hospitalizations for patients with SIPD was six times higher, and the structure of substance use-related morbidity underwent a transformation: a 2.9-fold decrease in the annual hospitalization rates for opioid dependence syndrome, accompanied by a 16.4-fold increase in hospitalizations for psychostimulant dependence syndrome, a 3.1-fold increase for cannabinoid dependence, and a 7.4-fold increase for dependence on other psychoactive substances and their combinations. According to the regression analysis, half of the variability in the hospitalization indicator for SIPD is explained by the hospitalization indicator for dependence on psychostimulants or other psychoactive substances and their combinations, while the other half is explained by the hospitalization rate for dependence on cannabinoids. CONCLUSION: The sixfold increase in the hospitalization rate for SIPDs observed in Russia since 2013 may be linked to changes in general drug use patterns — rise in the hospitalization rates for dependence syndromes on synthetic stimulants, cannabinoids and other psychoactive substances and their combinations, accompanied by a decline in hospitalizations for opioid dependence.
- Open Access
- 3 August 2026
- Published by Medical Informational Agency Publishers in Psychiatry (Moscow) (Psikhiatriya)
- Vol. 24 (3) , 20-30
Negative Symptoms Associated with Psychotic Disorders Induced by Narcotic Substances
Background : the characteristics of negative symptoms of drug-induced psychotic disorders (PD) caused by narcotic substances (NS) remain incompletely understood, which impedes the differential diagnosis with schizophrenia . The aim was to compare the presentation and severity of negative symptoms after psychotic disorders induced by the narcotic substances and schizophrenic psychosis in determining their significance for differential diagnosis. Patients and Methods : an observational cross-sectional study was conducted involving 141 patients, who were divided into 4 groups: 1) 21 patients with PD caused by natural cannabinoids; 2) 56 patients with PD induced by the synthetic cathinones; 3) 29 patients with PD induced by the several NS; 4) 35 patients with schizophrenia. Negative symptoms were assessed using the CAINS clinical interview, adapted for the Russian-speaking population. Statistical analysis included nonparametric methods of comparing multiple groups and subsequent post hoc analysis. Results : patients with schizophrenia had statistically significantly more pronounced negative symptoms on the emotional expressiveness subscale compared to all groups of narcotic-induced psychoses (p < 0.001). According to the CAINS total score, patients with schizophrenia differed signficantly from the synthetic cathinones-induced PD and several narcotic-induced PD groups (p < 0.001), but not from the natural cannabinoids-induced PD group (p = 0.47). Patients with natural cannabinoids-induced PD demonstrated the most pronounced negative symptoms among all groups of narcotics-induced psychoses, which were similar to schizophrenia in all areas, except emotional expressiveness. The synthetic cathinones-indused PD and several narcotic-induced PD groups were characterized by significantly less pronounced anticipatory negative symptoms and better motivation in the social, professional, and recreational spheres than patients with schizophrenia. Conclusion : significant differences in the profile of negative symptoms between psychotic disorders induced by different NS were identified. PD induced by natural cannabinoids were the closest ones to schizophrenia in the severity of negative symptoms, which is clinically significant for differential diagnosis and planning rehabilitation measures.
- 3 August 2026
- Published by Medical Informational Agency Publishers in Psychiatry (Moscow) (Psikhiatriya)
- Vol. 24 (3) , 20-30
Open AccessNegative Symptoms Associated with Psychotic Disorders Induced by Narcotic Substances
Background : the characteristics of negative symptoms of drug-induced psychotic disorders (PD) caused by narcotic substances (NS) remain incompletely understood, which impedes the differential diagnosis with schizophrenia . The aim was to compare the presentation and severity of negative symptoms after psychotic disorders induced by the narcotic substances and schizophrenic psychosis in determining their significance for differential diagnosis. Patients and Methods : an observational cross-sectional study was conducted involving 141 patients, who were divided into 4 groups: 1) 21 patients with PD caused by natural cannabinoids; 2) 56 patients with PD induced by the synthetic cathinones; 3) 29 patients with PD induced by the several NS; 4) 35 patients with schizophrenia. Negative symptoms were assessed using the CAINS clinical interview, adapted for the Russian-speaking population. Statistical analysis included nonparametric methods of comparing multiple groups and subsequent post hoc analysis. Results : patients with schizophrenia had statistically significantly more pronounced negative symptoms on the emotional expressiveness subscale compared to all groups of narcotic-induced psychoses (p < 0.001). According to the CAINS total score, patients with schizophrenia differed signficantly from the synthetic cathinones-induced PD and several narcotic-induced PD groups (p < 0.001), but not from the natural cannabinoids-induced PD group (p = 0.47). Patients with natural cannabinoids-induced PD demonstrated the most pronounced negative symptoms among all groups of narcotics-induced psychoses, which were similar to schizophrenia in all areas, except emotional expressiveness. The synthetic cathinones-indused PD and several narcotic-induced PD groups were characterized by significantly less pronounced anticipatory negative symptoms and better motivation in the social, professional, and recreational spheres than patients with schizophrenia. Conclusion : significant differences in the profile of negative symptoms between psychotic disorders induced by different NS were identified. PD induced by natural cannabinoids were the closest ones to schizophrenia in the severity of negative symptoms, which is clinically significant for differential diagnosis and planning rehabilitation measures.
- 28 April 2026
- Published by Bentham Science Publishers Ltd. in Current Psychopharmacology
- Vol. 14
The Potential of Synthetic Cathinones to Block the Membrane Dopamine Transporter: A Summary of Our Molecular Docking Results and Data from In vitro and In vivo Experiments in the Literature
Introduction: The behavioral sensitization (BS) model for psychostimulants is the most developed framework for explaining the occurrence of drug-induced psychoses. However, there is limited data on the potential of synthetic cathinones (SCs) to induce BS, which restricts the model’s full application in understanding this phenomenon. Aim: This study aimed to provide theoretical evidence regarding the potential of synthetic cathinones to inhibit the dopamine membrane transporter at levels sufficient to induce behavioral sensitization. Methods: The following SCs were selected as ligands: 4-methylmethcathinone (mephedrone), 3,4- methylenedioxypyrovalerone (MDPV), and alpha-pyrrolidinovalerophenone (alpha-PVP). Amphetamine and cocaine were included for comparison. Molecular docking was performed using Auto- Dock Vina and the Attracting Cavities algorithms. The human dopamine transporter structure was obtained from the Protein Data Bank (PDB ID: 8Y2DS). Additionally, PubMed, CNKI, and eLibrary databases were searched to compare the docking results with experimental data from cell lines and animal studies; 13 publications were included in the analysis. Results: All synthetic cathinones studied showed no significant differences in binding affinity to the orthosteric site of the dopamine membrane transporter, suggesting that they may act similarly to amphetamine and cocaine. These findings were corroborated by experiments in cell lines. For mephedrone and MDPV, the potential to induce behavioral sensitization (BS) was also confirmed in animal studies. Conclusion: Theoretically, mephedrone, MDPV, and alpha-PVP can inhibit the dopamine membrane transporter, leading to increased extracellular dopamine levels and promoting the development of dopamine hypersensitivity and behavioral sensitization.
- 28 April 2026
- Published by Bentham Science Publishers Ltd. in Current Psychopharmacology
- Vol. 14
The Potential of Synthetic Cathinones to Block the Membrane Dopamine Transporter: A Summary of Our Molecular Docking Results and Data from In vitro and In vivo Experiments in the Literature
Introduction: The behavioral sensitization (BS) model for psychostimulants is the most developed framework for explaining the occurrence of drug-induced psychoses. However, there is limited data on the potential of synthetic cathinones (SCs) to induce BS, which restricts the model’s full application in understanding this phenomenon. Aim: This study aimed to provide theoretical evidence regarding the potential of synthetic cathinones to inhibit the dopamine membrane transporter at levels sufficient to induce behavioral sensitization. Methods: The following SCs were selected as ligands: 4-methylmethcathinone (mephedrone), 3,4- methylenedioxypyrovalerone (MDPV), and alpha-pyrrolidinovalerophenone (alpha-PVP). Amphetamine and cocaine were included for comparison. Molecular docking was performed using Auto- Dock Vina and the Attracting Cavities algorithms. The human dopamine transporter structure was obtained from the Protein Data Bank (PDB ID: 8Y2DS). Additionally, PubMed, CNKI, and eLibrary databases were searched to compare the docking results with experimental data from cell lines and animal studies; 13 publications were included in the analysis. Results: All synthetic cathinones studied showed no significant differences in binding affinity to the orthosteric site of the dopamine membrane transporter, suggesting that they may act similarly to amphetamine and cocaine. These findings were corroborated by experiments in cell lines. For mephedrone and MDPV, the potential to induce behavioral sensitization (BS) was also confirmed in animal studies. Conclusion: Theoretically, mephedrone, MDPV, and alpha-PVP can inhibit the dopamine membrane transporter, leading to increased extracellular dopamine levels and promoting the development of dopamine hypersensitivity and behavioral sensitization.
- 31 March 2026
- Published by Ryazan State Medical University in Nauka Molodykh (Eruditio Juvenium)
- Vol. 14 (1)
Preliminary Data on the Relationship between Prospective Thinking, Autoaggressive Behavior and Clinical Parameters Identified in Patients with Opioid Dependence
BACKGROUND: Opioid dependence remains a global problem associated with a high risk of self-harming behavior and impaired prospective thinking (PT). The relationship between these factors and clinical outcomes remains unclear. AIM: To study the relationship between the characteristics of PT, autoaggressive behavior, remission period and adherence to treatment in patients with opioid dependence. METHODS: The cross-sectional study included 62 patients (11.3% women, mean age 35.6 years). The following instruments were used: Zimbardo Time Perspective Inventory (ZTPI), Future Thinking Task (FTT), Prosuicidal Strain Index (PSI), Barratt Impulsiveness Scale-11 (BIS-11), Beck Hopelessness Inventory, and Suicide Risk Inventory (SRI). Statistical analysis was performed in Stat Tech 4.7.0 (Mann–Whitney U-test, Spearman correlation). RESULTS: Patients in remission for more than 6 months generated more positive future events (FTT: p <0.05) and were future-oriented (ZTPI: p=0.002). The group in remission for less than 6 months demonstrated increased impulsivity (BIS-11: p=0.039) and incompetence (SRI: p <0.001). CONCLUSION: Impaired PT and autoaggressive behavior are associated with an unfavorable course of opioid dependence. Introduction of PT correction methods can improve the prognosis.
- 31 March 2026
- Published by Ryazan State Medical University in Nauka Molodykh (Eruditio Juvenium)
- Vol. 14 (1)
Preliminary Data on the Relationship between Prospective Thinking, Autoaggressive Behavior and Clinical Parameters Identified in Patients with Opioid Dependence
BACKGROUND: Opioid dependence remains a global problem associated with a high risk of self-harming behavior and impaired prospective thinking (PT). The relationship between these factors and clinical outcomes remains unclear. AIM: To study the relationship between the characteristics of PT, autoaggressive behavior, remission period and adherence to treatment in patients with opioid dependence. METHODS: The cross-sectional study included 62 patients (11.3% women, mean age 35.6 years). The following instruments were used: Zimbardo Time Perspective Inventory (ZTPI), Future Thinking Task (FTT), Prosuicidal Strain Index (PSI), Barratt Impulsiveness Scale-11 (BIS-11), Beck Hopelessness Inventory, and Suicide Risk Inventory (SRI). Statistical analysis was performed in Stat Tech 4.7.0 (Mann–Whitney U-test, Spearman correlation). RESULTS: Patients in remission for more than 6 months generated more positive future events (FTT: p <0.05) and were future-oriented (ZTPI: p=0.002). The group in remission for less than 6 months demonstrated increased impulsivity (BIS-11: p=0.039) and incompetence (SRI: p <0.001). CONCLUSION: Impaired PT and autoaggressive behavior are associated with an unfavorable course of opioid dependence. Introduction of PT correction methods can improve the prognosis.
- 25 February 2026
- Published by PANORAMA Publishing House in Vestnik Nevrologii, Psihiatrii i Nejrohirurgii (Bulletin of Neurology, Psychiatry and Neurosurgery)
- No. 2,p. 253-263
The effect of prospective thinking and self-destructive behavior characteristics on the duration of therapeutic remission in stimulant addiction
In order to analyze the factors influencing remission duration in patients with stimulant dependence syndrome, specifically parameters of self-destructive behavior and prospective thinking, a study was conducted involving 112 hospitalized patients – 73 women and 39 men diagnosed with stimulant dependence syndrome (F15.2 according to ICD-10). The median age was 24 years [21.00 ÷ 27.00]. Upon admission, patients completed Beck's Hopelessness Scale, Barratt Impulsiveness Scale, Stages of Change Readiness and Treatment Eagerness Scale (SOCRATES), as well as Interpersonal Needs Questionnaire and Zimbardo Time Perspective Inventory. Additionally, Suicidal Potential Index was calculated. At discharge, patients were retested using Beck's Hopelessness Scale and SOCRATES methodology. After discharge, patients were followed up for six months. Remission factor evaluation was performed using multiple linear regression method. A total of three multiple linear regression models were constructed, assessing multicollinearity and normal distribution of residuals. Study results confirm the multifactorial nature of formation and maintenance of remission in patients with stimulant dependence syndrome. The obtained data emphasize the importance of comprehensive treatment approach including work on negative cognitive schemas, development of prospective thinking, and maintaining motivation for change. Inclusion of therapeutic techniques that enhance planning abilities and stimulate prospective thinking may contribute to increased remission duration in patients with stimulant dependence syndrome.
- 25 February 2026
- Published by PANORAMA Publishing House in Vestnik Nevrologii, Psihiatrii i Nejrohirurgii (Bulletin of Neurology, Psychiatry and Neurosurgery)
- No. 2,p. 253-263
The effect of prospective thinking and self-destructive behavior characteristics on the duration of therapeutic remission in stimulant addiction
In order to analyze the factors influencing remission duration in patients with stimulant dependence syndrome, specifically parameters of self-destructive behavior and prospective thinking, a study was conducted involving 112 hospitalized patients – 73 women and 39 men diagnosed with stimulant dependence syndrome (F15.2 according to ICD-10). The median age was 24 years [21.00 ÷ 27.00]. Upon admission, patients completed Beck's Hopelessness Scale, Barratt Impulsiveness Scale, Stages of Change Readiness and Treatment Eagerness Scale (SOCRATES), as well as Interpersonal Needs Questionnaire and Zimbardo Time Perspective Inventory. Additionally, Suicidal Potential Index was calculated. At discharge, patients were retested using Beck's Hopelessness Scale and SOCRATES methodology. After discharge, patients were followed up for six months. Remission factor evaluation was performed using multiple linear regression method. A total of three multiple linear regression models were constructed, assessing multicollinearity and normal distribution of residuals. Study results confirm the multifactorial nature of formation and maintenance of remission in patients with stimulant dependence syndrome. The obtained data emphasize the importance of comprehensive treatment approach including work on negative cognitive schemas, development of prospective thinking, and maintaining motivation for change. Inclusion of therapeutic techniques that enhance planning abilities and stimulate prospective thinking may contribute to increased remission duration in patients with stimulant dependence syndrome.
- 30 December 2025
- Published by Ryazan State Medical University in PERSONALITY IN A CHANGING WORLD: HEALTH, ADAPTATION, DEVELOPMENT
- Vol. 13 (4 (51))
ADAPTATION AND VALIDATION OF THE COMPUTERIZED VERSION OF THE EDINBURGH HANDEDNESS INVENTORY FOR RUSSIAN LANGUAGE:PILOT STUDY
One of the most widely used text questionnaires in the world for determining the lateralization of brain functions is the Edinburgh Handedness Inventory (EHI). It was developed for use with mentally healthy respondents as well as patients with mental disorders. This method has not been adapted or validated in the Russian language. The aim of this study is to translate, adapt, and validate the Edinburgh Handedness Inventory (EHI) method implemented on the Inquisit computer platform. In the first stage, specialists with knowledge of English performed a direct and reverse translation of the method. Two groups of respondents were randomly recruited: people without mental disorders (UPZ, N=30) and patients diagnosed with schizophrenia (PS, N=32). Each respondent completed the EHI methodology (two times) , the Annette test, and a battery of tests to assess frontal lobe dysfunction. Cronbach's alpha coefficient for the UPZ group was 0.98, and for the PS group the coefficient was 0.96. A positive statistically significant correlation was found between responses to even and odd items of the EHI. Test-retest reliability was demonstrated for all parameters of the EHI. The laterality coefficient of the EHI method correlates positively with the Annette test result, which confirms convergent validity, and does not correlate with the results of the battery of tests for frontal lobe dysfunction, which confirms divergent validity. Thus, sufficient evidence has been obtained of the reliability and validity of the Edinburgh Handedness Inventory (EHI) methodology, translated and adapted into Russian and implemented on the Inquisit computer platform.
- 30 December 2025
- Published by Ryazan State Medical University in PERSONALITY IN A CHANGING WORLD: HEALTH, ADAPTATION, DEVELOPMENT
- Vol. 13 (4 (51))
ADAPTATION AND VALIDATION OF THE COMPUTERIZED VERSION OF THE EDINBURGH HANDEDNESS INVENTORY FOR RUSSIAN LANGUAGE:PILOT STUDY
One of the most widely used text questionnaires in the world for determining the lateralization of brain functions is the Edinburgh Handedness Inventory (EHI). It was developed for use with mentally healthy respondents as well as patients with mental disorders. This method has not been adapted or validated in the Russian language. The aim of this study is to translate, adapt, and validate the Edinburgh Handedness Inventory (EHI) method implemented on the Inquisit computer platform. In the first stage, specialists with knowledge of English performed a direct and reverse translation of the method. Two groups of respondents were randomly recruited: people without mental disorders (UPZ, N=30) and patients diagnosed with schizophrenia (PS, N=32). Each respondent completed the EHI methodology (two times) , the Annette test, and a battery of tests to assess frontal lobe dysfunction. Cronbach's alpha coefficient for the UPZ group was 0.98, and for the PS group the coefficient was 0.96. A positive statistically significant correlation was found between responses to even and odd items of the EHI. Test-retest reliability was demonstrated for all parameters of the EHI. The laterality coefficient of the EHI method correlates positively with the Annette test result, which confirms convergent validity, and does not correlate with the results of the battery of tests for frontal lobe dysfunction, which confirms divergent validity. Thus, sufficient evidence has been obtained of the reliability and validity of the Edinburgh Handedness Inventory (EHI) methodology, translated and adapted into Russian and implemented on the Inquisit computer platform.
- Open Access
- 30 September 2025
- Published by ECO-Vector LLC (Publications) in Neurology Bulletin
- Vol. LVII (3) , 274-283
Validation of the Russian version of the Continuous Performance Test—Identical Pairs tool Implemented on the Inquisit software platform
BACKGROUND: Impairments in selective attention are a major indicator of cognitive deficit in schizophrenia. However, there is a lack of psychodiagnostic tools adapted into Russian for the objective and accurate evaluation of such impairments. AIM: To translate into Russian, adapt, and validate the Continuous Performance Test—Identical Pairs (CPT-IP) tool implemented on the Inquisit software platform. METHODS: In total, 67 individuals were examined: 34 presumed mentally healthy individuals (15 men, 19 women, average age 22.5 [20.0; 43.3] years); 33 patients with schizophrenia (13 men, 20 women, average age 37.2 [25.2; 48.5] years). A translation of the original English-language CPT–IP script was performed and validated by the authors of the tool. The Russian version was made available in the Inquisit library. For each participant, a study was conducted using the Russian-language CPT–IP script, the cancellation test, the number search test and the ten-word recall test, as well as a retest using CPT–IP. RESULTS: The Cronbach’s alpha coefficient was 0.73 for both samples, reflecting a sufficient internal consistency of the method. A statistically significant negative correlation was found between the DPrime indicators in CPT–IP and the number of errors in the cancellation test, which confirms the convergent validity of CPT–IP for assessing selective attention. Discriminant validity was demonstrated by the absence of significant correlations between the CPT–IP indicators and the results of the ten-word recall test in both samples. The test-retest reliability reached a significantly high level according to the Chaddock scale. CONCLUSION: The translated into Russian and adapted CPT–IP tool has a sufficient internal consistency, convergent and discriminant validity, as well as a sufficient test-retest reliability, which allows recommending it for use in research on cognitive impairments in patients with schizophrenia.
- 30 September 2025
- Published by ECO-Vector LLC (Publications) in Neurology Bulletin
- Vol. LVII (3) , 274-283
Open AccessValidation of the Russian version of the Continuous Performance Test—Identical Pairs tool Implemented on the Inquisit software platform
BACKGROUND: Impairments in selective attention are a major indicator of cognitive deficit in schizophrenia. However, there is a lack of psychodiagnostic tools adapted into Russian for the objective and accurate evaluation of such impairments. AIM: To translate into Russian, adapt, and validate the Continuous Performance Test—Identical Pairs (CPT-IP) tool implemented on the Inquisit software platform. METHODS: In total, 67 individuals were examined: 34 presumed mentally healthy individuals (15 men, 19 women, average age 22.5 [20.0; 43.3] years); 33 patients with schizophrenia (13 men, 20 women, average age 37.2 [25.2; 48.5] years). A translation of the original English-language CPT–IP script was performed and validated by the authors of the tool. The Russian version was made available in the Inquisit library. For each participant, a study was conducted using the Russian-language CPT–IP script, the cancellation test, the number search test and the ten-word recall test, as well as a retest using CPT–IP. RESULTS: The Cronbach’s alpha coefficient was 0.73 for both samples, reflecting a sufficient internal consistency of the method. A statistically significant negative correlation was found between the DPrime indicators in CPT–IP and the number of errors in the cancellation test, which confirms the convergent validity of CPT–IP for assessing selective attention. Discriminant validity was demonstrated by the absence of significant correlations between the CPT–IP indicators and the results of the ten-word recall test in both samples. The test-retest reliability reached a significantly high level according to the Chaddock scale. CONCLUSION: The translated into Russian and adapted CPT–IP tool has a sufficient internal consistency, convergent and discriminant validity, as well as a sufficient test-retest reliability, which allows recommending it for use in research on cognitive impairments in patients with schizophrenia.
- 15 March 2025
- Published by ECO-Vector LLC in Neurology Bulletin
- Vol. LVII (1) , 46-53
Substance-induced schizophrenia: possible pathogenetic mechanisms
This brief report presents a narrative literature review describing potential pathogenetic mechanisms underlying the transformation of drug-induced psychoses into chronic psychotic disorders of the schizophrenic spectrum. The central role of hyperdopaminergia in the development of productive psychotic symptoms is discussed, along with the possibility of dopamine D2 receptor sensitization resulting from prolonged use of stimulant drugs. Attention is drawn to the previously described phenomenon of reverse tolerance, the study of which at genetic, molecular, neurotransmitter, and clinical levels may offer a promising approach for clinical assessment of prognosis and prevention of schizophrenia in individuals with a history of substance use.
- 15 March 2025
- Published by ECO-Vector LLC in Neurology Bulletin
- Vol. LVII (1) , 46-53
Substance-induced schizophrenia: possible pathogenetic mechanisms
This brief report presents a narrative literature review describing potential pathogenetic mechanisms underlying the transformation of drug-induced psychoses into chronic psychotic disorders of the schizophrenic spectrum. The central role of hyperdopaminergia in the development of productive psychotic symptoms is discussed, along with the possibility of dopamine D2 receptor sensitization resulting from prolonged use of stimulant drugs. Attention is drawn to the previously described phenomenon of reverse tolerance, the study of which at genetic, molecular, neurotransmitter, and clinical levels may offer a promising approach for clinical assessment of prognosis and prevention of schizophrenia in individuals with a history of substance use.
- 27 December 2024
- Published by ECO-Vector LLC in I.P. Pavlov Russian Medical Biological Herald
- Vol. 32 (4) , 595-606
Stimulation of future thinking in stimulant–depending patients using questionnaire–based structured interview
INTRODUCTION: Impaired future thinking (FT) a human ability to imagine and comprehend images and scenarios of the personal future may contribute to the severity of psychoactive substance dependence. Spontaneous mental images of the impacts of using psychoactive substances and/or of one’s own death (‘flash-forwards’), as well as impaired arbitrary modeling of future images (for example, overgeneralization and lack of reflection) interfere with adherence to treatment and stability of remission in addictions. AIM: To evaluate the influence of FT-activating intervention on treatment outcomes in patients with narcotic psychostimulant dependence. MATERIALS AND METHODS: A randomized prospective controlled clinical trial conducted in 2021–2023 involved 112 inpatients with stimulant dependence (F15.2). Of them, the main group consisted of 56 patients (age 24.0 [21.0; 27.0] years; 30.4% of men), who underwent FT stimulation in the form of semi-structured interview based on the Russian pilot version of the Impact of Future Events Scale (IFES). The control group consisted of 56 patients (age 23.5 [22.0; 26.0] years; 39.3% of men) who received a standard drug addiction conversation of equal duration. The treatment result parameters included the score on the Stages of Change Readiness and Treatment Eagerness Scale (SOCRATES); duration of remission, participation in long-term therapy, in outpatient rehabilitation, inpatient rehabilitation, confirmation of the fact of prescheduled discharge, infringement of regime, incarcerations. The test was conducted upon admission and after discharge. Hospitals stay period — 21 days, follow-up period — 6 months. RESULTS: At the hospitalization stage, the groups did not differ in socio-demographic and main clinical parameters (p 0.05). SOCRATES scores were higher in the control group 49.0 [47.0; 49.0] versus 48.0 [47.0; 49.0] (p = 0.040). At the stage of re-test before discharge, the main group showed an improvement in motivation according to SOCRATES and significantly outperformed the control group: 67.0 [65.3; 68.0] versus 50.0 [48.0; 53.8] points (p 0.001). The main group had a longer duration of remission — 3.3 [0.5; 5.4] months versus 0.5 [0.4; 1.0] months (p = 0.001); fewer prescheduled discharges — 12.5% versus 50.0% (p = 0.001); more frequent visits to long-term therapy — 30.4% versus 8.9% (p = 0.01) and outpatient rehabilitation — 21.4% versus 1.8% (p = 0.001) respectively. CONCLUSIONS: FT-activating intervention directed to stimulating reflection of anxious and positive aspects of the personal future, contributes to increase in duration of remission in the catamnesis, increases motivation and adherence to treatment in patients with addiction to narcotic psychostimulants.
- 27 December 2024
- Published by ECO-Vector LLC in I.P. Pavlov Russian Medical Biological Herald
- Vol. 32 (4) , 595-606
Stimulation of future thinking in stimulant–depending patients using questionnaire–based structured interview
INTRODUCTION: Impaired future thinking (FT) a human ability to imagine and comprehend images and scenarios of the personal future may contribute to the severity of psychoactive substance dependence. Spontaneous mental images of the impacts of using psychoactive substances and/or of one’s own death (‘flash-forwards’), as well as impaired arbitrary modeling of future images (for example, overgeneralization and lack of reflection) interfere with adherence to treatment and stability of remission in addictions. AIM: To evaluate the influence of FT-activating intervention on treatment outcomes in patients with narcotic psychostimulant dependence. MATERIALS AND METHODS: A randomized prospective controlled clinical trial conducted in 2021–2023 involved 112 inpatients with stimulant dependence (F15.2). Of them, the main group consisted of 56 patients (age 24.0 [21.0; 27.0] years; 30.4% of men), who underwent FT stimulation in the form of semi-structured interview based on the Russian pilot version of the Impact of Future Events Scale (IFES). The control group consisted of 56 patients (age 23.5 [22.0; 26.0] years; 39.3% of men) who received a standard drug addiction conversation of equal duration. The treatment result parameters included the score on the Stages of Change Readiness and Treatment Eagerness Scale (SOCRATES); duration of remission, participation in long-term therapy, in outpatient rehabilitation, inpatient rehabilitation, confirmation of the fact of prescheduled discharge, infringement of regime, incarcerations. The test was conducted upon admission and after discharge. Hospitals stay period — 21 days, follow-up period — 6 months. RESULTS: At the hospitalization stage, the groups did not differ in socio-demographic and main clinical parameters (p 0.05). SOCRATES scores were higher in the control group 49.0 [47.0; 49.0] versus 48.0 [47.0; 49.0] (p = 0.040). At the stage of re-test before discharge, the main group showed an improvement in motivation according to SOCRATES and significantly outperformed the control group: 67.0 [65.3; 68.0] versus 50.0 [48.0; 53.8] points (p 0.001). The main group had a longer duration of remission — 3.3 [0.5; 5.4] months versus 0.5 [0.4; 1.0] months (p = 0.001); fewer prescheduled discharges — 12.5% versus 50.0% (p = 0.001); more frequent visits to long-term therapy — 30.4% versus 8.9% (p = 0.01) and outpatient rehabilitation — 21.4% versus 1.8% (p = 0.001) respectively. CONCLUSIONS: FT-activating intervention directed to stimulating reflection of anxious and positive aspects of the personal future, contributes to increase in duration of remission in the catamnesis, increases motivation and adherence to treatment in patients with addiction to narcotic psychostimulants.